eXmoor Pharma
PrivateLast Round
Series A
May 30, 2023
Total Funding Raised
$36.8M
Company Overview
eXmoor Pharma operates in Healthcare & Life Sciences and is based in Bristol. Its latest recorded funding round was a Series A round in May 2023.
eXmoor Pharma is a cell and gene therapy company that provides contract development and manufacturing (CDMO) services, including consultancy, process development, and GMP manufacturing.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery, Pharma Supply Chain, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
eXmoor Pharma Comparables
Compare eXmoor Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| RoslinCT | 88% | |
| Kincell Bio | 88% | |
| Genezen | 84% |
For institutional investors. Book with your work email.
eXmoor Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 30, 2023 | ||||
| VC Round | Mar 11, 2021 | ||||
| Grant | Feb 23, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
eXmoor Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kineticos Ventures | Series A |
| Innovate UK | Grant |
| Medical Research Council | Grant |
| MVM Life Science Partners LLP | Series A, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
eXmoor Pharma and the Translational Research Office (TRO) at University College London (UCL) have formed a strategic collaboration to accelerate the development of novel cell and gene therapies (CGTs) from academic research into clinical application.
- Nov 9, 2025
Monthly visitors grew 69% MoM, reaching 2.6K.
For institutional investors. Book with your work email.
eXmoor Pharma Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about eXmoor Pharma's valuation, stock price, and market status.
Is eXmoor Pharma a public or private company?
eXmoor Pharma is a private company.
What is the current stock price of eXmoor Pharma?
eXmoor Pharma is a private company, so its shares have no public market price. Caplight tracks eXmoor Pharma's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is eXmoor Pharma worth (valuation)?
Valuation information for eXmoor Pharma is not publicly available.
Can I buy eXmoor Pharma stock?
eXmoor Pharma shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was eXmoor Pharma's last funding round?
eXmoor Pharma's most recent funding round was Series A on May 30, 2023.
Who are the main investors in eXmoor Pharma?
Key investors in eXmoor Pharma include Kineticos Ventures, MVM Life Science Partners LLP.
Will eXmoor Pharma IPO soon?
No public IPO plans have been announced for eXmoor Pharma.
How can I track eXmoor Pharma secondary market activity?
Caplight tracks bids, offers, and trades in eXmoor Pharma's shares on secondary markets.